Clinical trial Recruiting at 1 site Observational Ages 70 and up

Improving osteoporosis care for older women

Official title: A Qualitative Exploration of Older Women and Primary Healthcare Professional Experiences to Guide Improvements in Osteoporosis Care

Run by Bradford Institute for Health Research · NCT06431867 · Data updated 2026-11-12

This study is trying to find better ways to help older women with osteoporosis by working with both patients and doctors to create useful care guidelines.

Quick facts

Study typeObservational
Ages70 Years and up
SexAll
Enrollment60 (estimated)
SponsorBradford Institute for Health Research
Academic / other
Locations1 site (Bradford, West Yorkshire)
StatusRecruiting
StartedSeptember 16, 2024
Main results expectedMarch 2025
Study endsSeptember 2025
Registry record updatedFebruary 4, 2025
Trial IDNCT06431867 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are community-dwelling women aged 70 and older who have been diagnosed with osteoporosis.

Probably not a fit

Patients who are under 70 years old, lack the capacity to consent, or reside in care homes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance primary care management of osteoporosis specifically for older women by engaging with both patients and healthcare professionals. The investigators will conduct ethnographic meta-analysis, in-depth interviews, and co-production workshops to gather insights and develop strategies that address the unique needs of this demographic. By synthesizing evidence from previous research and direct feedback from participants, the study seeks to create effective guidelines for osteoporosis care in primary settings. The focus is on empowering older women and healthcare providers to improve the quality of care they receive.

Why it matters

Potential benefit: If successful, this study could lead to improved osteoporosis management and outcomes for older women, reducing fractures and associated healthcare costs.

How similar studies have gone: While there is existing literature on osteoporosis care, this approach of co-production with older women and healthcare professionals is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Older women:

* Osteoporosis diagnosis - either self-reported following a clinical diagnosis or taken from the patient's medical record in the case of the Community Ageing Research 75+ (CARE75+) cohort and Fracture Liaison Service (FLS) patients.
* Aged 70 years or older to align with the recommendation from our preliminary engagement work.
* Community dwelling.

Healthcare professionals:

• Working in the National Health Service (NHS) in England to align with the participant sample.

Exclusion criteria

Older women:

* Aged under 70 years.
* Lacks capacity to consent to participate in research.
* Resident in a care home - care home residents are likely to need different types of interventions than community dwelling older women as there are organisational considerations.
* Member of the co-production workshop.

Healthcare professionals:

* Not performing any NHS work.
* \< 12 months in NHS practice.

Where it's running

  • Bradford Institute for Health Research
    Bradford, West Yorkshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.